Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04169711
Recruitment Status : Recruiting
First Posted : November 20, 2019
Last Update Posted : April 19, 2021
Sponsor:
Information provided by (Responsible Party):
Arrowhead Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 30, 2022
Estimated Study Completion Date : March 30, 2022